J Korean Med Assoc.  2015 Jun;58(6):523-533. 10.5124/jkma.2015.58.6.523.

Lung cancer screening with low-dose chest computed tomography: recent radiologic advances

Affiliations
  • 1Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea. keyrad@korea.ac.kr

Abstract

Lung cancer is the leading cause of cancer-related death worldwide. Most patients are diagnosed with advanced disease, resulting in a poor prognosis. Screening may induce the early detection of lung cancer and early detection of lung cancer may reduce lung cancer-related mortality. Recently, the National Lung Screening Trial has demonstrated that lung cancer screening with low-dose chest computed tomography (LDCT) showed a 20% reduction in lung cancer-related mortality and a 6.7% decrease in all-cause mortality in the US. Based on the results of National Lung Screening Trial, various lung cancer-related societies recommend lung cancer screening using LDCT in asymptomatic populations at high risk based on old age and a heavy smoking history. For effective and responsible lung cancer screening, LDCT should be performed at sites providing high-quality low-radiation exposure computed tomography (CT). LDCT must be performed with multidetector helical CT in a single breath-hold and use adequate technical parameters. CT is interpreted accurately by qualified physicians. And structured reporting and management system should be recommended for high quality reporting and medical outcomes monitoring. Adverse events associated with LDCT screening may include a high detection rate of lung nodules and high false positive results, overdiagnosis, and relatively high radiation exposure. However, lung cancer screening with LDCT can result in more benefits than harms when performed in settings with high quality screening programs.

Keyword

Radiology; Multidetector computed tomography; Pulmonary nodule; Lung neoplasms

MeSH Terms

Humans
Lung
Lung Neoplasms*
Mass Screening*
Mortality
Multidetector Computed Tomography
Prognosis
Smoke
Smoking
Thorax*
Tomography, Spiral Computed
Smoke

Figure

  • Figure 1 Examples of (A) solid nodule, (B) part-solid nodule, and (C) pure ground glass nodule.


Cited by  1 articles

Recent trends in radiology
Eun-Young Kang
J Korean Med Assoc. 2015;58(6):499-501.    doi: 10.5124/jkma.2015.58.6.499.


Reference

1. Korea Central Cancer Registry. 2012 Statistics on the national cancer registry. Goyang: National Cancer Center;2014.
2. National Lung Screening Trial Research Team. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365:395–409.
Article
3. Moyer VA. US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160:330–338.
Article
4. Kazerooni EA, Armstrong MR, Amorosa JK, Hernandez D, Liebscher LA, Nath H, McNitt-Gray MF, Stern EJ, Wilcox PA. ACR CT accreditation program and the lung cancer screening program designation. J Am Coll Radiol. 2015; 12:38–42.
Article
5. American College of Radiology. Lung CT screening reporting and data system (Lung-RADS) [Internet]. Reston: American College of Radiology;2014. cited 2015 May 19. Available from: http://www.acr.org/Quality-Safety/Resources/LungRADS.
6. Lee HJ, Kim JH, Kim YK, Park CM, Yi CA, Jeong YJ. Korean Society of Thoracic Radiology guideline for lung cancer screening with low-dose CT. J Korean Soc Radiol. 2012; 67:349–365.
Article
7. Korean National Cancer Screening Guideline Revision Committee. The Korean guideline for lung cancer screening (the first draft). Seoul: Korean National Cancer Screening Guideline Revision Committee;2014.
8. Manser R, Lethaby A, Irving LB, Stone C, Byrnes G, Abramson MJ, Campbell D. Screening for lung cancer. Cochrane Database Syst Rev. 2013; 6:CD001991.
Article
9. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed. American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143:e78S–e92S.
10. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, Passera E, Angeli E, Chiarenza M, Aranzulla G, Cariboni U, Errico V, Inzirillo F, Bottoni E, Voulaz E, Alloisio M, Destro A, Roncalli M, Santoro A, Ravasi G. DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009; 180:445–453.
Article
11. Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, Dossing M, Hansen H, Kofoed KF, Larsen KR, Mortensen J, Rasmussen JF, Seersholm N, Skov BG, Thorsen H, Tonnesen P, Pedersen JH. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012; 67:296–301.
Article
12. Pastorino U, Rossi M, Rosato V, Marchiano A, Sverzellati N, Morosi C, Fabbri A, Galeone C, Negri E, Sozzi G, Pelosi G, La Vecchia C. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012; 21:308–315.
13. International Early Lung Cancer Action Program Investigators. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006; 355:1763–1771.
Article
14. Lee HJ, Kim JH, Kim YK, Park CM, Yi CA, Jeong YJ. Lung cancer screening with low-dose CT: potential benefits and potential harms. J Korean Soc Thorac Radiol. 2012; 1 Suppl. S1–S7.
15. Kazerooni EA, Austin JH, Black WC, Dyer DS, Hazelton TR, Leung AN, McNitt-Gray MF, Munden RF, Pipavath S. ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4). J Thorac Imaging. 2014; 29:310–316.
Article
16. American Association for Physicists in Medicine. CT scan protocols [Internet]. College Park: American Association for Physicists in Medicine;cited 2015 May 19. Available from: http://www.aapm.org/pubs/CTProtocols/?tab¼5#CTPanel.
17. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012; 307:2418–2429.
18. No. 65. Regulations for Installation and Management of Special Medical Equipmen, Pub. L. 2011. 06. 27.
19. Korean Society of Radiology. Guidelines for quality assurance of CT. The Korean Society of Radiology. Guidelines for quality assurance of special medical equipment. Seoul: Korean Society of Radiology;2013. p. 12–28.
20. Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC. American College of Chest Physicians. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132:94S–107S.
21. McKee BJ, Regis SM, McKee AB, Flacke S, Wald C. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol. 2015; 12:273–276.
Article
22. Van Hamersvelt RW, Willemink MJ, Takx RA, Eikendal AL, Budde RP, Leiner T, Mol CP, Isgum I, de Jong PA. Cardiac valve calcifications on low-dose unenhanced ungated chest computed tomography: inter-observer and inter-examination reliability, agreement and variability. Eur Radiol. 2014; 24:1557–1564.
Article
23. Jacobs PC, Prokop M, van der Graaf Y, Gondrie MJ, Janssen KJ, de Koning HJ, Isgum I, van Klaveren RJ, Oudkerk M, van Ginneken B, Mali WP. Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. Atherosclerosis. 2010; 209:455–462.
Article
24. Prokop M. Lung cancer screening: the radiologis's perspective. Semin Respir Crit Care Med. 2014; 35:91–98.
25. Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemagi MC, Chiles C, Black WC, Aberle DR. NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014; 174:269–274.
Article
26. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Mandrekar JN. 5-Year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest. 2009; 136:1586–1595.
27. Esserman LJ, Thompson IM Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013; 310:797–798.
28. McCunney RJ, Li J. Radiation risks in lung cancer screening programs: a comparison with nuclear industry workers and atomic bomb survivors. Chest. 2014; 145:618–624.
29. Lee SM, Lee HJ. Low-dose CT for lung cancer screening: radiation risk. J Korean Soc Thorac Radiol. 2012; 1 Suppl. S8–S11.
Full Text Links
  • JKMA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr